SRPT Past Earnings image   This SRPT past earnings page last updated 5/23/2022
SRPT Past Earnings
PeriodPast Earnings DateAdj. EPS
Q1 20225/4/2022-0.560
Q4 20213/1/2022-0.770
Q3 202111/3/2021-0.190
Q2 20218/4/2021-1.520
Q1 20215/5/2021-1.540
Q4 20203/1/2021-1.840
Q3 202011/5/2020-1.420
Q2 20208/5/2020-1.510
Q1 20205/6/2020-1.040
Q4 20192/26/2020-1.570
Q3 201911/7/2019-1.140
Q2 20198/7/2019-0.830
Q1 20195/8/2019-0.750
Q4 20182/27/2019-0.85
Q3 201810/24/2018-0.56
Q2 20188/8/2018-0.43
Q1 20185/3/2018-0.28
Q4 20173/1/2018-0.28
Q3 201710/25/2017-0.2
Q2 20177/19/2017-0.46
Q1 20174/27/2017-0.6
Q4 20162/28/2017-0.71
Q3 201610/27/2016-0.95
Q2 20167/19/2016-1.19
Q1 20165/5/2016-1.15
Q4 20152/25/2016-1.3
Q3 201511/5/2015-1.11
Q2 20158/6/2015-0.87
Q1 20155/7/2015-1.15
Q4 20142/26/2015-0.94
Q3 201411/6/2014-0.7
Q2 20148/7/2014-0.61
Q1 20145/8/2014-0.55
Q4 20132/27/2014-0.77
Q3 201311/12/2013-0.63
Q2 20138/8/2013-0.46
Q1 20135/9/2013-0.41
Q4 20123/7/2013-2.36
Q3 201211/7/2012-2.170
Q2 20128/7/20120.36
SRPT Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/4/20220.21B
Q4 20213/1/20220.20B
Q3 202111/3/20210.19B
Q2 20218/4/20210.16B
Q1 20215/5/20210.15B
Q4 20203/1/20210.15B
Q3 202011/5/20200.14B
Q2 20208/5/20200.14B
Q1 20205/6/20200.11B
Q4 20192/26/20200.10B
Q3 201911/7/20190.10B
Q2 20198/7/20190.09B
Q1 20195/8/20190.09B
Q4 20182/27/201984.42M
Q3 201810/24/201878.49M
Q2 20188/8/201873.53M
Q1 20185/3/201864.60M
Q4 20173/1/201857.28M
Q3 201710/25/201745.95M
Q2 20177/19/201735.01M
Q1 20174/27/201716.34M
Q4 20162/28/20175.42M
Q3 201610/27/2016NA
Q2 20167/19/2016NA
Q1 20165/5/2016NA
Q4 20152/25/20161.25M
Q3 201511/5/2015NA
Q2 20158/6/2015NA
Q1 20155/7/2015NA
Q4 20142/26/201527000
Q3 201411/6/20141.10M
Q2 20148/7/20142.60M
Q1 20145/8/20146.09M
Q4 20132/27/20142.60M
Q3 201311/12/20134.17M
Q2 20138/8/20133.00M
Q1 20135/9/20134.50M
Q4 20123/7/20137.30M
Q3 201211/7/20120.01B
Q2 20128/7/201211.20M
Quotes delayed 20 minutes

Email EnvelopeFree SRPT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Sarepta Therapeutics (SRPT) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

SRRA Historical Earnings
SRRK Historical Earnings
SRTS Historical Earnings
SSKN Historical Earnings
STAA Historical Earnings
STAB Historical Earnings
STE Historical Earnings
STIM Historical Earnings
STOK Historical Earnings
STRO Historical Earnings

SRPT Past Earnings Q&A

What was the best and worst SRPT past earnings results?
For Sarepta Therapeutics, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest SRPT past earnings result in our data set was 0.36/share posted in Q2 2012, while the lowest was in Q4 2012 when SRPT posted -2.36/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q1 2022 when SRPT reported 0.21B in revenue, while the quarter with the lowest revenue in our data set was Q3 2016 at NA of revenue.

  Suggested answer: There are 40 SRPT past earnings results in our data set.

On this page we presented the SRPT past earnings date information for Sarepta Therapeutics. Reviewing that SRPT Past Earnings for the company, we see that the highest past earnings result in our data set was in Q2 2012, when SRPT posted adjusted EPS of 0.36/share. Meanwhile the lowest SRPT past earnings result was in Q4 2012, when SRPT posted adjusted EPS of -2.36/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q1 2022 when SRPT reported 0.21B in revenue, while the smallest revenue quarter was Q3 2016 when SRPT reported NA in revenue.

Any self directed investor doing their due diligence on SRPT or any other given stock can benefit from researching all of the Sarepta Therapeutics past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Sarepta Therapeutics past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for SRPT. Thanks for visiting, and the next time you need to research SRPT past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: Top Ten Hedge Funds Holding FARM, BCTF Average Annual Return, Top Ten Hedge Funds Holding ATW.

 

SRPT Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.